Acer Therapeutics Inc (NASDAQ:ACER)

17.28
Delayed Data
As of 4:00pm ET
 -0.88 / -4.83%
Today’s Change
5.70
Today|||52-Week Range
22.63
+24.77%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close18.16
Today’s open17.81
Day’s range17.28 - 18.15
Volume23,188
Average volume (3 months)25,785
Market cap$133.8M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+44.88%
Earnings growth (this year)+82.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.65%
P/E ratioNM
Price/Sales2.23
Price/Book4.63

Competitors

 Today’s
change
Today’s
% change
EVFMEvofem Biosciences I...-0.03-0.39%
--Achieve Life Science...-0.02-1.43%
MBVXMabVax Therapeutics ...+0.04+1.91%
CPHIChina Pharma Holding...+0.02+4.87%
Data as of 3:59pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$2.9M
Annual profit (last year)-$8.0M
Net profit margin-274.69%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Cambridge, Massachusetts

Forecasts